BG Medicine, Inc. reported unaudited consolidated earnings results for the fourth quarter and full year ended December 31, 2014. For the quarter, the company reported total revenues of $554,000 against $1,149,000 a year ago. Loss from operations was $1,211,000 against $1,661,000 a year ago. Net loss was $1,319,000 against $1,935,000 a year ago. Basic and diluted loss per share was $0.04 against $0.06 a year ago. The decrease in total revenues reflected a $330,000 decrease in product revenues and a $265,000 decrease in service revenues from the prior year quarter.

For the year, the company reported total revenues of $2,787,000 against $4,073,000 a year ago. Loss from operations was $7,362,000 against $14,374,000 a year ago. Net loss was $8,064,000 against $15,849,000 a year ago. Basic and diluted loss per share was $0.25 against $0.58 a year ago. Net cash used in operating activities was $8,167,000 against $15,288,000 a year ago.